Ethinylestradiol + Drospirenone
Yasmin is a combined oral contraceptive. Each coated tablet contains two different hormones. These are: ethinylestradiol (estrogen) and drospirenone (progestogen). When using Yasmin according to the recommendations in this leaflet, the likelihood of becoming pregnant is very low. One should remember that Yasmin, like other combined oral contraceptives, does not protect against HIV infection (AIDS) and sexually transmitted diseases.
Prevention of pregnancy.
Before starting to use Yasmin, one should read the information about blood clots (thrombosis) in point 2. It is especially important to read about the symptoms of blood clots (see point 2 "Blood clots"). Every year, about 1 in 100 women who use combined oral contraceptives correctly become pregnant. This number may increase if tablets are missed or not taken correctly.
Yasmin should not be used if the patient has any of the conditions listed below. If the patient has any of the conditions listed below, they should inform their doctor. The doctor will discuss with the patient which other contraceptive method will be more suitable.
If any of the symptoms listed above occur for the first time while taking Yasmin, the medicine should be stopped immediately and a doctor consulted. In the meantime, non-hormonal methods of contraception should be used (see also "General notes"). Yasmin should not be used if the patient has hepatitis C and is taking antiviral medicines containing ombitasvir, paritaprevir, ritonavir, and dasabuvir (see also "Yasmin and other medicines").
Children and adolescents
Yasmin is not intended for use in girls who have not yet started their menstrual cycle.
Women of advanced age
Yasmin is not intended for use after menopause.
Women with liver function disorders
Yasmin should not be taken if the patient has liver disease. See also "When not to use Yasmin" and "Warnings and precautions".
Women with kidney function disorders
Yasmin should not be taken if the patient has kidney failure or acute kidney failure. See also "When not to use Yasmin" and "Warnings and precautions".
When to contact a doctor
One should contact a doctor immediately
In order to get a description of the serious side effects listed, see "How to recognize the occurrence of blood clots".
If combined oral contraceptives are used in any of the situations listed below, close medical supervision is necessary. If these symptoms appear or worsen while taking Yasmin, one should also tell the doctor.
Thrombosis is the formation of blood clots that can block a blood vessel. Thrombosis sometimes occurs in the deep veins of the legs (deep vein thrombosis). If a blood clot breaks loose from where it is formed, it can block the arteries in the lungs and cause pulmonary embolism. Deep vein thrombosis is rare; it can occur even when not taking the medicine, e.g. during pregnancy. The use of combined hormonal contraceptives such as Yasmin is associated with an increased risk of blood clots compared to not using them. In rare cases, a blood clot can block a blood vessel and cause serious complications. Blood clots can form:
One should contact a doctor immediately if they notice any of the following symptoms. Is the patient experiencing any of these symptoms? Why is the patient likely to be suffering from it?
Pulmonary embolism
If the patient is unsure, they should contact a doctor, as some of these symptoms, such as cough or shortness of breath, may be mistaken for milder conditions, such as a respiratory infection (e.g. a cold). Symptoms usually occur in one eye:
| Heart attack |
| Stroke |
| Blood clots blocking other blood vessels |
The risk of blood clots in a vein is highest during the first year of using combined hormonal contraceptives for the first time. The risk may also be higher when resuming the use of combined hormonal contraceptives (the same or a different medicine) after a break of 4 weeks or more. After the first year, the risk decreases, but it is always higher compared to not using combined hormonal contraceptives. If the patient stops using Yasmin, the risk of blood clots returns to normal within a few weeks.
The risk of blood clots associated with Yasmin is small, but some factors can increase this risk. The risk is higher:
Air travel (>4 hours) may temporarily increase the risk of blood clots, especially if the patient has another risk factor. One should tell their doctor if any of the risk factors are present, even if they are not sure. The doctor may decide to stop using Yasmin. One should inform their doctor if any of the above conditions change while using Yasmin, e.g. if they start smoking, if someone in their immediate family is diagnosed with a blood clot without a known cause, or if they gain significant weight.
Similarly to blood clots in veins, blood clots in arteries can cause serious consequences, such as a heart attack or stroke.
It should be emphasized that the risk of heart attack or stroke associated with Yasmin is very small, but it may increase:
If the patient has more than one of the above conditions or if any of them are particularly severe, the risk of blood clots may be even higher. One should inform their doctor if any of the above conditions change while using Yasmin, e.g. if they start smoking, if someone in their immediate family is diagnosed with a blood clot without a known cause, or if they gain significant weight. If symptoms suggesting a blood clot occur, one should stop taking the tablets and consult a doctor immediately (see also "When to contact a doctor").
In women who use combined oral contraceptives, breast cancer is slightly more common than in women of the same age who do not use them. It is not known whether this difference is caused solely by the use of hormonal contraceptives. The reason may also be that women who use hormonal contraceptives are more often examined and breast cancer is detected earlier in them. The described difference in the incidence of breast cancer decreases gradually and disappears within 10 years after stopping the use of combined oral contraceptives. In women who use combined oral contraceptives, benign or, even more rarely, malignant liver tumors have been rarely reported, which can cause life-threatening bleeding into the abdominal cavity. If severe abdominal pain occurs, one should inform their doctor as soon as possible. There are reports of a more common occurrence of cervical cancer in women who use combined oral contraceptives for a long time. However, this relationship may not be related to the use of the tablets, but to sexual behavior or other factors.
Some women who use hormonal contraceptives, including Yasmin, have reported depression or low mood. Depression can be severe and sometimes lead to suicidal thoughts. If mood changes and symptoms of depression occur, one should contact a doctor as soon as possible to receive further medical advice.
Some medicines may:
This applies to medicines:
Yasmin should not be used if the patient has hepatitis C and is taking antiviral medicines containing ombitasvir, paritaprevir, ritonavir, and dasabuvir, as this may cause elevated liver function test results (increased level of the liver enzyme ALT). The doctor will propose a different type of contraception before starting these medicines. One can resume using Yasmin about 2 weeks after finishing the treatment. See point "When not to use Yasmin". Before using any medicine, one should consult a doctor or pharmacist. One should always inform their doctor about any medicines or herbal products they are already taking. One should also tell any other doctor, including a dentist or pharmacist, who prescribes another medicine, that they are using Yasmin. They may say that additional contraceptive measures should be used (e.g. condoms), and if so, for how long.
Before using any medicine, one should consult a doctor or pharmacist. Yasmin is not recommended during pregnancy or if pregnancy is suspected. If pregnancy is suspected, one should consult a doctor as soon as possible.
Before using any medicine, one should consult a doctor or pharmacist. Yasmin is not recommended during breast-feeding.
No influence of Yasmin on the ability to drive and use machines has been observed.
One should contact a doctor immediately if:
The situations and symptoms listed above are described in more detail in other parts of this leaflet.
If the patient has been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
Yasmin should always be used according to the doctor's recommendations. In case of doubts, one should contact their doctor again. Yasmin, like other oral contraceptives, does not protect against HIV infection (AIDS) and sexually transmitted diseases.
After taking the entire package (21 tablets), one does not take tablets for the next 7 days. During this time, withdrawal bleeding occurs. It usually starts on the 2nd or 3rd day after taking the last tablet of Yasmin. One starts taking tablets from the next package after a 7-day break. During the 7-day break in taking tablets, there is no need to use additional methods of contraception, provided that the tablets were taken according to the recommended schedule, and the next package is started after 7 days.
One starts taking tablets from the next package after a 7-day break. Each new package will be started on the same day of the week as the previous one, so it is easy to remember when to start the new package. One starts taking tablets from the next package after a 7-day break, even if the withdrawal bleeding is still ongoing.
If a different combined oral contraceptive was used for 21 days
After taking all the tablets from the package of a different combined oral contraceptive for 21 days, there is a 7-day break, after which Yasmin is started. The first tablet of Yasmin should be taken on the day of the week marked on the tablet, and then one should follow the instructions described in the point "Taking Yasmin for the first time". If one starts using Yasmin in this way, its contraceptive effect will be maintained. Withdrawal bleeding may not occur before finishing the first package of Yasmin, but this is not a cause for concern. During the days of taking the tablets, minor bleeding may occur, but this is also not a cause for concern.
If a different combined oral contraceptive was used for 28 days
If a different combined oral contraceptive was used for 28 days, one should start taking Yasmin the day after taking the last tablet of the previous contraceptive. The first tablet of Yasmin should be taken on the day of the week marked on the tablet, and then one should follow the instructions described in the point "Taking Yasmin for the first time". If one follows the above recommendations, there is no need to use additional methods of contraception. Withdrawal bleeding may not occur before finishing the first package of Yasmin, but this is not a cause for concern. During the days of taking the tablets, minor bleeding may occur, but this is also not a cause for concern. If a vaginal ring or transdermal patch is used, one should start taking Yasmin on the day the ring or patch is removed, but no later than the day a new ring or patch would be applied.
If a progestogen-only pill (minipill) was used earlier
One can stop taking the minipill on any day and instead, at the same time, start taking Yasmin. If sexual intercourse is maintained during the first 7 days of taking Yasmin, one should use additional methods of contraception (barrier methods).
If progestogen injections, an implant, or an intrauterine system were used earlier
One should start taking Yasmin on the day the next injection would be due or on the day the implant or intrauterine system is removed. If sexual intercourse is maintained during the first 7 days of taking the tablets, one should use additional methods of contraception (barrier methods).
After a miscarriage in the first trimester of pregnancy
One can start taking Yasmin immediately. In this case, there is no need to use additional methods of contraception.
After childbirth or a miscarriage in the second trimester of pregnancy
One should start taking tablets between the 21st and 28th day after childbirth or miscarriage in the second trimester of pregnancy. If one starts using the tablets later, one should use additional mechanical contraception for the first 7 days of taking the tablets. If sexual intercourse has occurred before starting to use a combined oral contraceptive, one should make sure they are not pregnant or wait for the first menstrual period.
Nausea, vomiting, or vaginal bleeding may occur. This type of bleeding may occur even in girls who have not yet started their menstrual cycle, but have taken the medicine by mistake. There are no reports of serious side effects after taking multiple tablets of Yasmin at the same time. If a higher dose of Yasmin than recommended has been taken, or if someone else has taken it, one should inform their doctor.
The medicine can be stopped at any time. The doctor will propose other methods of contraception. If one stops taking Yasmin because they want to become pregnant, they should wait until they have a natural menstrual period. This will help determine the expected date of birth of the child.
If less than 12 hourshave passed since missing a tablet, the contraceptive effect of Yasmin is maintained. One should take the missed tablet as soon as possible and take the next one at the usual time.
If more than 12 hourshave passed since missing a tablet or if more than one tablet has been missed, the contraceptive effect of Yasmin may be reduced. Therefore, the patient must use additional methods of contraception. The more consecutive tablets are missed, the higher the risk of reduced contraceptive effectiveness.
One should consult their doctor.
One should take the missed tablet as soon as possible (even if it means taking two tablets at the same time), and take the next ones at the usual time. For the next 7 days, one should use additional methods of contraception (barrier methods). If sexual intercourse was maintained during the week preceding the missed tablet, it is possible to become pregnant. One should contact their doctor as soon as possible.
One should take the missed tablet as soon as possible (even if it means taking two tablets at the same time), and take the next ones at the usual time. The contraceptive effect of Yasmin is maintained, and there is no need to use additional methods of contraception. However, if errors were made in dosing earlier or if more than one tablet was missed, one should use additional mechanical contraception for 7 days.
One can choose one of the following options, without the need to use additional methods of contraception, provided that the correct dosing was followed for 7 days preceding the missed dose. If not, one should use the first of the two options below and use additional mechanical contraception for 7 days.
One can also stop taking the tablets from the current package, take a 7-day or shorter break (including the day the tablet was missed), and then continue taking the tablets from the next package. If a tablet is missed and during the first break in taking the tablets, withdrawal bleeding does not occur, it is possible that one is pregnant. Before starting the next package of Yasmin, one should consult their doctor.
Like any drug, Yasmin can cause side effects, although not everyone will experience them.
If any side effects occur, especially severe and persistent ones, or changes in health that you consider related to the use of the Yasmin drug, you should consult a doctor.
In all women taking combined hormonal contraceptives, there is an increased risk of blood clots in the veins (venous thromboembolism) or blood clots in the arteries (arterial thromboembolism). To obtain detailed information about the various risk factors associated with the use of combined hormonal contraceptives, you should read section 2 "Important information before using the Yasmin drug".
Severe side effects related to the use of the Yasmin drug and their symptoms are described in the following sections of the leaflet: "Blood clots" and "Yasmin drug and cancer". You should read these sections to obtain additional information and, if necessary, immediately consult a doctor.
Below are the symptoms reported by patients taking the Yasmin drug, although they may not have been caused by the drug.
Common (in more than 1 in 100 people and less than 1 in 10 people):
Uncommon (in more than 1 in 1000 people and less than 1 in 100 people):
o myocardial infarction
o stroke
o mini-stroke or transient stroke-like symptoms, known as a transient ischemic attack
o blood clots in the liver, stomach, and intestine, kidneys, or eye
The likelihood of blood clots may be higher if you have any other risk factors (see section 2 for more information about risk factors for blood clots and symptoms of blood clots).
In women with hereditary angioedema, exogenous estrogens may cause the occurrence or worsening of its symptoms.
In some people, during the use of the Yasmin drug, other side effects may occur.
If you experience any side effects, including any side effects not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help gather more information on the safety of the drug.
The drug should be stored in a place invisible and inaccessible to children.
Store at a temperature below 30°C. Store in the original packaging.
Do not use after the expiration date stated on the packaging.
The expiration date means the last day of the given month.
Drugs should not be thrown into the sewage system or household waste containers. You should ask your pharmacist how to dispose of unused drugs. This will help protect the environment.
Each coated tablet contains 0.03 mg of ethinylestradiol and 3 mg of drospirenone.
Excipients:
Core:
lactose monohydrate
corn starch
corn starch, pregelatinized
povidone K 25
magnesium stearate
Coating:
hypromellose
macrogol 6000
talc
titanium dioxide (E 171)
yellow iron oxide (E 172)
The package contains blisters of PVC/Al foil with 21 or 63 coated tablets in a cardboard box.
To obtain more detailed information, you should contact the marketing authorization holder or the parallel importer.
Bayer B.V.
Energieweg 1
3641 RT Mijdrecht
Netherlands
Bayer AG
Müllerstrasse 178
13353 Berlin
Germany
Medezin Sp. z o.o.
Zbąszyńska 3 Street
91-342 Łódź
Medezin Sp. z o.o.
Zbąszyńska 3 Street
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
Działkowa 56 Street
02-234 Warsaw
SHIRAZ PRODUCTIONS Sp. z o.o.
Tymiankowa 24/28 Street
95-054 Ksawerów
CANPOLAND SPÓŁKA AKCYJNA
Beskidzka 190 Street
91-610 Łódź
Marketing authorization number in the Netherlands, the country of export: RVG 23827
MA
Date of leaflet approval: 13.12.2022
[Information about the reserved trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.